Amyotrophic lateral scloresuis details answer with pt mangement and assessment
"amyotrophic lateral sclerosis"[MeSH Terms] AND management
| Feature | Data |
|---|---|
| Incidence | ~2 per 100,000/year |
| Prevalence | 5-8 per 100,000 |
| Peak age at onset | 55-74 years |
| Male:Female ratio | ~1.6:1 (slight female predominance in bulbar-onset) |
| Sporadic vs Familial | ~90% sporadic, 5-10% familial |
| Mean survival | 2-5 years from symptom onset |
| Familial inheritance | Usually autosomal dominant |

| Diagnostic Level | Criteria |
|---|---|
| Clinically Definite ALS | Clinical or electrophysiologic UMN and LMN signs in ≥3 regions |
| Clinically Probable ALS | UMN and LMN signs in ≥2 regions, with some UMN signs rostral to LMN signs |
| Clinically Possible ALS | UMN and LMN in only 1 region, OR UMN signs alone in ≥2 regions, OR LMN signs rostral to UMN signs |
| Drug | Mechanism | Effect |
|---|---|---|
| Riluzole (sodium glutamate antagonist) | Blocks glutamate release, reduces excitotoxicity | Extends survival ~2-3 months; slows decline; standard of care |
| Edaravone | Free radical scavenger, reduces oxidative stress | Confirmed in double-blind RCT; slows functional decline in selected patients |
| Tofersen (antisense oligonucleotide) | Targets SOD1 mRNA; reduces mutant SOD1 protein | For SOD1-ALS; emerging gene therapy approach |
| AMX0035 (sodium phenylbutyrate + taurursodiol) | Anti-apoptotic, mitochondrial protective | FDA approved 2022 for ALS |
| Symptom | Pharmacotherapy | Non-pharmacological |
|---|---|---|
| Spasticity | Baclofen, tizanidine, dantrolene, diazepam | Physiotherapy, range-of-motion exercises, botulinum toxin |
| Muscle cramps | Quinine sulfate, baclofen, vitamin E, clonazepam | Massage, physiotherapy |
| Fatigue | Pyridostigmine, amantadine, modafinil, methylphenidate, antidepressants | Energy conservation, work modification, BiPAP if sleep apnea |
| Sialorrhea (drooling) | Hyoscyamine, glycopyrrolate, scopolamine patch, diphenhydramine, atropine | Suction machine, botulinum toxin into salivary glands, parotid gland radiation |
| Thick phlegm | Nebulized N-acetylcysteine, nebulized saline, propranolol | Insufflation-exsufflation (cough assist), cool mist humidifier |
| Pseudobulbar affect | TCAs, SSRIs, lithium, mirtazapine, quinidine/dextromethorphan (Nuedexta) | |
| Depression/anxiety | TCAs, SSRIs, venlafaxine, mirtazapine, bupropion | Counseling, support groups |
| Pain/joint pain | NSAIDs, analgesics | Range-of-motion exercises, heat |
| Fasciculations | Carbamazepine | Reassurance |
| Jaw clenching | Benzodiazepines | Botulinum toxin into masseters |
| Aspiration | Cisapride | Modified food consistency, thickened liquids, tracheostomy in severe cases |
| Insomnia | Zolpidem, zopiclone, TCAs | Sleep hygiene, BiPAP |
Physiotherapy assessment and management
Which condition/context is this physiotherapy assessment and management for?
"amyotrophic lateral sclerosis"[MeSH Terms] AND "physical therapy"[MeSH Terms]
"amyotrophic lateral sclerosis" AND "exercise" AND rehabilitation
PMID: 38762656
PMID: 40273110
PMID: 41375893
PMID: 39182937
PMID: 40488544
PMID: 42038869
| Stage | Features | Physio Focus |
|---|---|---|
| Stage 1 | Diagnosis; independently ambulant; minor deficits | Exercise, education, prevention |
| Stage 2a | Independent but with some functional limitation | Adaptive exercise, orthotics |
| Stage 2b | Dependent for some ADLs; still ambulant | Energy conservation, wheelchair |
| Stage 3 | Wheelchair dependent; upper limb function reduced | Positioning, passive ROM, respiratory |
| Stage 4 | Dependent for most ADLs | Pressure care, carer training |
| Stage 5 | End-stage; respiratory support, minimal movement | Comfort, palliative, communication |
| ALS Stage | Primary Physio Goals | Key Interventions |
|---|---|---|
| Early | Maintain function, prevent deconditioning | Moderate aerobic + strengthening exercise, education, gait assessment, respiratory baseline |
| Middle | Maximise independence, prevent falls, respiratory support | AFO, walking aids, ROM exercises, airway clearance techniques, NIV planning, fatigue management |
| Late | Maintain comfort and dignity, prevent complications | Wheelchair, positioning, pressure care, cough assist/NIV, carer training |
| End-stage | Comfort, symptom control | Palliative positioning, secretion management, family support |
| Measure | What it Assesses |
|---|---|
| ALSFRS-R | Overall function (0-48) |
| MRC Sum Score | Global muscle strength |
| FVC (seated and supine) | Respiratory function |
| SNIP / MIP / MEP | Respiratory muscle strength |
| Peak Cough Flow (PCF) | Cough effectiveness |
| Fatigue Severity Scale (FSS) | Fatigue severity |
| Berg Balance Scale (BBS) | Balance |
| Timed Up and Go (TUG) | Mobility |
| 10-Metre Walk Test | Gait speed |
| Visual Analog Scale (VAS) | Pain |
| McGill Quality of Life Questionnaire | QoL |
| Study | Finding |
|---|---|
| Li & Kang, Sci Rep 2024 (Network meta-analysis, 12 RCTs) | Exercise intervention had the greatest benefit on ALSFRS-R, FVC, QoL and MRC sum score among all non-pharmacological ALS interventions |
| Silva et al., BMJ Open 2024 (Systematic review) | Physiotherapy may improve short-term global function; no serious adverse events; evidence quality still low |
| Souza et al., PLoS One 2025 (Systematic review + meta-analysis) | Strengthening exercise is safe in ALS; no serious adverse events; inconclusive superiority vs. control due to small study sizes |
| Benzo-Iglesias et al., Ther Adv Respir Dis 2025 (Systematic review + meta-analysis, 5 RCTs) | Respiratory muscle training improves MIP and MEP; one study shows inspiratory training may predict survival |
| Gratzer et al., J Clin Med 2025 (Clinical review) | Evidence supports moderate tailored exercise, early respiratory therapy, spasticity and mobility management as key physiotherapy elements in ALS |
Create a structured physiotherapy intake form for ALS assessment
mkdir -p /home/daytona/workspace/als-intake-form && ls /home/daytona/workspace/als-intake-form/
~/als-intake-form/generate_form.js
const {
Document, Packer, Paragraph, TextRun, Table, TableRow, TableCell,
AlignmentType, HeadingLevel, BorderStyle, WidthType, ShadingType,
VerticalAlign, PageNumber, Header, Footer, PageBreak,
UnderlineType
} = require('docx');
const fs = require('fs');
// ─── Helpers ────────────────────────────────────────────────────────────────
const TEAL = "1A7A8A";
const TEAL_LIGHT = "E6F4F6";
const GREY_LIGHT = "F5F5F5";
const WHITE = "FFFFFF";
const DARK = "1A1A2E";
const MID_GREY = "CCCCCC";
function sectionHeader(text) {
return new Paragraph({
heading: HeadingLevel.HEADING_1,
spacing: { before: 280, after: 100 },
shading: { type: ShadingType.SOLID, color: TEAL },
children: [
new TextRun({
text: text,
color: WHITE,
bold: true,
size: 24,
font: "Calibri",
}),
],
});
}
function subHeader(text) {
return new Paragraph({
spacing: { before: 200, after: 60 },
children: [
new TextRun({
text: text,
bold: true,
color: TEAL,
size: 22,
font: "Calibri",
underline: { type: UnderlineType.SINGLE, color: TEAL },
}),
],
});
}
function label(text) {
return new TextRun({ text, bold: true, size: 20, font: "Calibri", color: DARK });
}
function field(width = 3500) {
return new TextRun({ text: "_".repeat(Math.floor(width / 80)), size: 20, font: "Calibri", color: MID_GREY });
}
function labelLine(labelText, extraField = "") {
return new Paragraph({
spacing: { before: 80, after: 60 },
children: [
label(labelText + " "),
field(),
...(extraField ? [new TextRun({ text: " " }), label(extraField + " "), field()] : []),
],
});
}
function checkboxLine(labelText, options) {
const runs = [label(labelText + ": ")];
options.forEach((opt) => {
runs.push(new TextRun({ text: "\u25A1 " + opt + " ", size: 20, font: "Calibri" }));
});
return new Paragraph({ spacing: { before: 80, after: 60 }, children: runs });
}
function yesNoLine(labelText) {
return checkboxLine(labelText, ["Yes", "No"]);
}
function multiLine(labelText) {
return [
new Paragraph({
spacing: { before: 80, after: 20 },
children: [label(labelText)],
}),
new Paragraph({
spacing: { before: 0, after: 40 },
children: [new TextRun({ text: "_".repeat(120), size: 20, font: "Calibri", color: MID_GREY })],
}),
new Paragraph({
spacing: { before: 0, after: 60 },
children: [new TextRun({ text: "_".repeat(120), size: 20, font: "Calibri", color: MID_GREY })],
}),
];
}
function smallNote(text) {
return new Paragraph({
spacing: { before: 40, after: 40 },
children: [new TextRun({ text, size: 17, font: "Calibri", color: "888888", italics: true })],
});
}
function spacer() {
return new Paragraph({ spacing: { before: 60, after: 60 }, children: [new TextRun("")] });
}
// ─── Scoring Table ───────────────────────────────────────────────────────────
function scoreTable(title, rows) {
const headerRow = new TableRow({
tableHeader: true,
children: ["Domain", "Score", "Notes"].map((h) =>
new TableCell({
shading: { type: ShadingType.SOLID, color: TEAL },
children: [new Paragraph({
children: [new TextRun({ text: h, bold: true, color: WHITE, size: 20, font: "Calibri" })],
alignment: AlignmentType.CENTER,
})],
verticalAlign: VerticalAlign.CENTER,
})
),
});
const dataRows = rows.map((r, i) =>
new TableRow({
children: [
new TableCell({
shading: { type: ShadingType.SOLID, color: i % 2 === 0 ? GREY_LIGHT : WHITE },
width: { size: 40, type: WidthType.PERCENTAGE },
children: [new Paragraph({ children: [new TextRun({ text: r, size: 19, font: "Calibri" })] })],
}),
new TableCell({
shading: { type: ShadingType.SOLID, color: i % 2 === 0 ? GREY_LIGHT : WHITE },
width: { size: 20, type: WidthType.PERCENTAGE },
children: [new Paragraph({ children: [new TextRun({ text: "___/___", size: 19, font: "Calibri", color: MID_GREY })] })],
}),
new TableCell({
shading: { type: ShadingType.SOLID, color: i % 2 === 0 ? GREY_LIGHT : WHITE },
width: { size: 40, type: WidthType.PERCENTAGE },
children: [new Paragraph({ children: [new TextRun({ text: "________________________________", size: 19, font: "Calibri", color: MID_GREY })] })],
}),
],
})
);
return [
subHeader(title),
new Table({
width: { size: 100, type: WidthType.PERCENTAGE },
rows: [headerRow, ...dataRows],
}),
spacer(),
];
}
// ─── Two-column row helper ────────────────────────────────────────────────────
function twoColRow(left, right) {
return new Table({
width: { size: 100, type: WidthType.PERCENTAGE },
borders: {
top: { style: BorderStyle.NONE }, bottom: { style: BorderStyle.NONE },
left: { style: BorderStyle.NONE }, right: { style: BorderStyle.NONE },
insideH: { style: BorderStyle.NONE }, insideV: { style: BorderStyle.NONE },
},
rows: [
new TableRow({
children: [
new TableCell({ width: { size: 50, type: WidthType.PERCENTAGE }, children: [left] }),
new TableCell({ width: { size: 50, type: WidthType.PERCENTAGE }, children: [right] }),
],
}),
],
});
}
// ─── Muscle Strength Table ───────────────────────────────────────────────────
function muscleTable() {
const muscles = [
["Shoulder Abductors", "", ""],
["Elbow Flexors", "", ""],
["Elbow Extensors", "", ""],
["Wrist Extensors", "", ""],
["Finger Flexors", "", ""],
["Intrinsic Hand / Thenar", "", ""],
["Hip Flexors", "", ""],
["Knee Extensors", "", ""],
["Knee Flexors", "", ""],
["Ankle Dorsiflexors", "", ""],
["Ankle Plantar Flexors", "", ""],
["Neck Flexors", "", ""],
["Neck Extensors", "", ""],
];
const headerRow = new TableRow({
tableHeader: true,
children: ["Muscle Group", "R (MRC 0-5)", "L (MRC 0-5)", "Notes"].map((h) =>
new TableCell({
shading: { type: ShadingType.SOLID, color: TEAL },
children: [new Paragraph({
children: [new TextRun({ text: h, bold: true, color: WHITE, size: 19, font: "Calibri" })],
alignment: AlignmentType.CENTER,
})],
})
),
});
const dataRows = muscles.map((m, i) =>
new TableRow({
children: [
new TableCell({
shading: { type: ShadingType.SOLID, color: i % 2 === 0 ? GREY_LIGHT : WHITE },
width: { size: 40, type: WidthType.PERCENTAGE },
children: [new Paragraph({ children: [new TextRun({ text: m[0], size: 19, font: "Calibri" })] })],
}),
...["R", "L", "Notes"].map(() =>
new TableCell({
shading: { type: ShadingType.SOLID, color: i % 2 === 0 ? GREY_LIGHT : WHITE },
width: { size: 20, type: WidthType.PERCENTAGE },
children: [new Paragraph({ children: [new TextRun({ text: "________", size: 19, font: "Calibri", color: MID_GREY })] })],
})
),
],
})
);
return new Table({
width: { size: 100, type: WidthType.PERCENTAGE },
rows: [headerRow, ...dataRows],
});
}
// ─── ALSFRS-R Table ──────────────────────────────────────────────────────────
function alsfrTable() {
const items = [
"1. Speech",
"2. Salivation",
"3. Swallowing",
"4. Handwriting",
"5. Cutting Food / Utensils",
"6. Dressing / Hygiene",
"7. Turning in Bed",
"8. Walking",
"9. Climbing Stairs",
"10. Dyspnea",
"11. Orthopnea",
"12. Respiratory Insufficiency",
];
const headerRow = new TableRow({
tableHeader: true,
children: ["ALSFRS-R Item", "Score (0-4)", "Notes"].map((h) =>
new TableCell({
shading: { type: ShadingType.SOLID, color: TEAL },
children: [new Paragraph({
children: [new TextRun({ text: h, bold: true, color: WHITE, size: 19, font: "Calibri" })],
alignment: AlignmentType.CENTER,
})],
})
),
});
const dataRows = items.map((item, i) =>
new TableRow({
children: [
new TableCell({
shading: { type: ShadingType.SOLID, color: i % 2 === 0 ? GREY_LIGHT : WHITE },
width: { size: 50, type: WidthType.PERCENTAGE },
children: [new Paragraph({ children: [new TextRun({ text: item, size: 19, font: "Calibri" })] })],
}),
new TableCell({
shading: { type: ShadingType.SOLID, color: i % 2 === 0 ? GREY_LIGHT : WHITE },
width: { size: 15, type: WidthType.PERCENTAGE },
children: [new Paragraph({ alignment: AlignmentType.CENTER, children: [new TextRun({ text: "___/4", size: 19, font: "Calibri", color: MID_GREY })] })],
}),
new TableCell({
shading: { type: ShadingType.SOLID, color: i % 2 === 0 ? GREY_LIGHT : WHITE },
width: { size: 35, type: WidthType.PERCENTAGE },
children: [new Paragraph({ children: [new TextRun({ text: "________________________________", size: 19, font: "Calibri", color: MID_GREY })] })],
}),
],
})
);
const totalRow = new TableRow({
children: [
new TableCell({
shading: { type: ShadingType.SOLID, color: TEAL_LIGHT },
children: [new Paragraph({ children: [new TextRun({ text: "TOTAL SCORE", bold: true, size: 20, font: "Calibri" })] })],
}),
new TableCell({
shading: { type: ShadingType.SOLID, color: TEAL_LIGHT },
children: [new Paragraph({ alignment: AlignmentType.CENTER, children: [new TextRun({ text: "___/48", bold: true, size: 20, font: "Calibri", color: TEAL })] })],
}),
new TableCell({
shading: { type: ShadingType.SOLID, color: TEAL_LIGHT },
children: [new Paragraph({ children: [new TextRun({ text: "Rate of change: ___ pts/month", size: 19, font: "Calibri", italics: true })] })],
}),
],
});
return new Table({
width: { size: 100, type: WidthType.PERCENTAGE },
rows: [headerRow, ...dataRows, totalRow],
});
}
// ─── Respiratory Table ───────────────────────────────────────────────────────
function respiratoryTable() {
const params = [
["FVC Seated (%predicted)", "____%", "Normal >80%"],
["FVC Supine (%predicted)", "____%", "Drop >25% from seated = significant"],
["SNIP (cmH₂O)", "____", "<40 = significant impairment"],
["MIP (cmH₂O)", "____", "<60 = inspiratory muscle weakness"],
["MEP (cmH₂O)", "____", "<60 = impaired cough"],
["Peak Cough Flow (L/min)", "____", "<270 = retention risk; <160 = ineffective cough"],
["Oxygen Saturation (SpO₂)", "____%", ""],
["Respiratory Rate (/min)", "____", "Normal 12-20"],
["Nocturnal symptoms", "\u25A1 Yes \u25A1 No", "Headache / somnolence / orthopnea"],
];
const headerRow = new TableRow({
tableHeader: true,
children: ["Parameter", "Value", "Clinical Threshold"].map((h) =>
new TableCell({
shading: { type: ShadingType.SOLID, color: TEAL },
children: [new Paragraph({ children: [new TextRun({ text: h, bold: true, color: WHITE, size: 19, font: "Calibri" })] })],
})
),
});
const dataRows = params.map((p, i) =>
new TableRow({
children: p.map((cell) =>
new TableCell({
shading: { type: ShadingType.SOLID, color: i % 2 === 0 ? GREY_LIGHT : WHITE },
children: [new Paragraph({ children: [new TextRun({ text: cell, size: 19, font: "Calibri" })] })],
})
),
})
);
return new Table({ width: { size: 100, type: WidthType.PERCENTAGE }, rows: [headerRow, ...dataRows] });
}
// ─── Title Page ──────────────────────────────────────────────────────────────
function titleBlock() {
return [
new Paragraph({
alignment: AlignmentType.CENTER,
spacing: { before: 200, after: 60 },
shading: { type: ShadingType.SOLID, color: TEAL },
children: [
new TextRun({ text: " PHYSIOTHERAPY INTAKE & ASSESSMENT FORM", bold: true, size: 34, color: WHITE, font: "Calibri" }),
],
}),
new Paragraph({
alignment: AlignmentType.CENTER,
spacing: { before: 0, after: 40 },
shading: { type: ShadingType.SOLID, color: "155F6B" },
children: [
new TextRun({ text: " AMYOTROPHIC LATERAL SCLEROSIS (ALS / MND)", bold: true, size: 24, color: WHITE, font: "Calibri" }),
],
}),
new Paragraph({
alignment: AlignmentType.CENTER,
spacing: { before: 60, after: 160 },
children: [
new TextRun({ text: "Multidisciplinary ALS Clinic | Neurological Physiotherapy Department", size: 19, font: "Calibri", italics: true, color: "555555" }),
],
}),
];
}
// ─── Build Document ──────────────────────────────────────────────────────────
const children = [
// Title
...titleBlock(),
// ═══════════════════════════════════════════
// SECTION 1 – Patient Demographics
// ═══════════════════════════════════════════
sectionHeader("SECTION 1 — PATIENT DEMOGRAPHICS"),
spacer(),
labelLine("Patient Name:", "Date of Birth:"),
labelLine("MRN / Hospital No.:", "Date of Assessment:"),
labelLine("Referring Physician:", "Diagnosis Date:"),
labelLine("ALS Clinic / Centre:", "Therapist Name:"),
checkboxLine("ALS Type", ["Sporadic", "Familial"]),
checkboxLine("Onset Region", ["Spinal – Upper Limb", "Spinal – Lower Limb", "Bulbar", "Respiratory", "Unknown"]),
checkboxLine("Genetic Testing", ["Not done", "SOD1", "C9ORF72", "FUS/TLS", "TARDBP", "Other: ________"]),
labelLine("Emergency Contact Name:", "Relationship:"),
labelLine("Emergency Contact Phone:", ""),
spacer(),
// ═══════════════════════════════════════════
// SECTION 2 – Subjective History
// ═══════════════════════════════════════════
sectionHeader("SECTION 2 — SUBJECTIVE HISTORY"),
spacer(),
subHeader("2.1 Presenting Complaints"),
...multiLine("Chief complaint (in patient's own words):"),
labelLine("Date of first symptom:", "Body region first affected:"),
labelLine("Disease duration (months):", ""),
spacer(),
subHeader("2.2 Symptom Profile"),
checkboxLine("Current Symptoms", ["Weakness", "Fasciculations", "Muscle cramps", "Spasticity", "Fatigue"]),
checkboxLine("", ["Dysphagia", "Dysarthria", "Sialorrhea", "Dyspnea", "Orthopnea"]),
checkboxLine("", ["Foot drop", "Head drop", "Pain / joint stiffness", "Mood changes", "Sleep disturbance"]),
checkboxLine("Cognitive Changes", ["None", "Mild frontal", "Formal FTD diagnosis"]),
...multiLine("Other symptoms / notes:"),
spacer(),
subHeader("2.3 Functional History"),
checkboxLine("Mobility Status", ["Independently ambulant", "Ambulant with aid", "Wheelchair part-time", "Wheelchair full-time", "Bedbound"]),
checkboxLine("Walking Aid Used", ["None", "Walking stick", "Quad stick", "Rollator", "Forearm crutches", "Walker frame"]),
checkboxLine("Wheelchair", ["None", "Manual – self-propelled", "Manual – carer-propelled", "Powered – joystick", "Powered – alternative control"]),
labelLine("Approximate walking distance:", "Falls in past 3 months:"),
checkboxLine("ADL Independence", ["Fully independent", "Independent with aids", "Requires some assistance", "Fully dependent"]),
...multiLine("Activities most limited by ALS (patient-stated priorities):"),
spacer(),
subHeader("2.4 Fatigue Assessment"),
labelLine("Fatigue Severity Scale (FSS) Score:", "(threshold: >36 = significant fatigue)"),
checkboxLine("Post-exercise fatigue >30 minutes", ["Yes – reduce activity load", "No"]),
...multiLine("Fatigue pattern / triggers:"),
spacer(),
subHeader("2.5 Pain Assessment"),
yesNoLine("Current pain"),
labelLine("Pain location:", "NRS Score (0-10):"),
checkboxLine("Pain type", ["Spasticity-related", "Joint / mechanical", "Cramps", "Pressure area", "Neuropathic", "Other"]),
spacer(),
subHeader("2.6 Respiratory Symptoms"),
yesNoLine("Dyspnea on exertion"),
yesNoLine("Orthopnea (breathlessness when lying flat)"),
yesNoLine("Morning headaches"),
yesNoLine("Excessive daytime sleepiness"),
yesNoLine("Interrupted / poor-quality sleep"),
yesNoLine("Currently on NIV / BiPAP"),
labelLine("If on NIV – hours/night:", "Interface type:"),
spacer(),
subHeader("2.7 Social and Home Environment"),
checkboxLine("Living Situation", ["Alone", "With spouse/partner", "With family", "Supported accommodation", "Residential care"]),
checkboxLine("Home Type", ["Single storey", "Multi-storey – lift", "Multi-storey – stairs only", "Other"]),
yesNoLine("Home modifications in place (grab rails, ramp, stairlift, hospital bed)"),
labelLine("Primary carer:", "Carer availability (hrs/day):"),
yesNoLine("Carer trained in manual handling"),
checkboxLine("Employment Status", ["Working full-time", "Working part-time", "Reduced duties", "Unable to work", "Retired"]),
spacer(),
subHeader("2.8 Medical History & Medications"),
...multiLine("Relevant past medical history:"),
labelLine("Current medications relevant to PT:", ""),
checkboxLine("Disease-modifying therapy", ["Riluzole", "Edaravone", "Tofersen", "AMX0035", "None", "Clinical trial"]),
checkboxLine("Medications affecting PT", ["Baclofen", "Tizanidine", "Opioids", "Benzodiazepines", "None"]),
spacer(),
subHeader("2.9 Patient Goals"),
...multiLine("Short-term goals (1-3 months):"),
...multiLine("Long-term goals (3-12 months):"),
...multiLine("Priority activities to maintain:"),
spacer(),
// ═══════════════════════════════════════════
// SECTION 3 – Objective Assessment
// ═══════════════════════════════════════════
new Paragraph({ children: [new PageBreak()] }),
sectionHeader("SECTION 3 — OBJECTIVE ASSESSMENT"),
spacer(),
subHeader("3.1 General Observations"),
...multiLine("Posture, affect, nutritional status, communication, resting respiratory pattern:"),
spacer(),
subHeader("3.2 ALS Functional Rating Scale – Revised (ALSFRS-R)"),
smallNote("Score each item 0 (unable) to 4 (normal). Total score /48. Rate of decline >1 pt/month = faster progression."),
spacer(),
alsfrTable(),
spacer(),
// ═══════════════════════════════════════════
// SECTION 4 – Muscle Strength
// ═══════════════════════════════════════════
sectionHeader("SECTION 4 — MUSCLE STRENGTH (MRC SCALE)"),
smallNote("MRC Grade: 0 = No contraction | 1 = Flicker | 2 = Movement with gravity eliminated | 3 = Movement against gravity | 4 = Movement against resistance | 5 = Normal"),
spacer(),
muscleTable(),
spacer(),
labelLine("Grip Strength R (kg):", "Grip Strength L (kg):"),
labelLine("Pinch Strength R:", "Pinch Strength L:"),
...multiLine("Notes on asymmetry, fatigue, pattern of weakness:"),
spacer(),
// ═══════════════════════════════════════════
// SECTION 5 – Tone & Spasticity
// ═══════════════════════════════════════════
sectionHeader("SECTION 5 — TONE & SPASTICITY"),
spacer(),
checkboxLine("UMN Signs Present", ["Hyperreflexia", "Clonus", "Babinski sign", "Hoffman sign", "Spasticity"]),
checkboxLine("LMN Signs Present", ["Hyporeflexia/areflexia", "Fasciculations", "Muscle wasting"]),
...scoreTable("Modified Ashworth Scale (MAS)", [
"Shoulder / Elbow (R)",
"Shoulder / Elbow (L)",
"Wrist / Finger flexors (R)",
"Wrist / Finger flexors (L)",
"Hip flexors / Adductors (R)",
"Hip flexors / Adductors (L)",
"Ankle plantar flexors (R)",
"Ankle plantar flexors (L)",
]),
...multiLine("Functional impact of spasticity:"),
spacer(),
// ═══════════════════════════════════════════
// SECTION 6 – Range of Motion
// ═══════════════════════════════════════════
sectionHeader("SECTION 6 — RANGE OF MOTION"),
spacer(),
labelLine("Shoulder Flexion R:", "L:"),
labelLine("Shoulder Abduction R:", "L:"),
labelLine("Elbow Extension R:", "L:"),
labelLine("Wrist Extension R:", "L:"),
labelLine("Finger Extension R:", "L:"),
labelLine("Hip Extension R:", "L:"),
labelLine("Knee Extension R:", "L:"),
labelLine("Ankle Dorsiflexion R:", "L:"),
checkboxLine("Contractures Present", ["None", "Shoulder", "Elbow", "Wrist", "Finger", "Hip", "Knee", "Ankle"]),
...multiLine("Notes:"),
spacer(),
// ═══════════════════════════════════════════
// SECTION 7 – Respiratory Assessment
// ═══════════════════════════════════════════
new Paragraph({ children: [new PageBreak()] }),
sectionHeader("SECTION 7 — RESPIRATORY ASSESSMENT"),
spacer(),
respiratoryTable(),
spacer(),
checkboxLine("Paradoxical breathing (abdominal wall movement)", ["Present", "Absent"]),
checkboxLine("Cough effectiveness", ["Effective", "Weak but functional", "Ineffective – cough assist needed"]),
checkboxLine("Secretion management", ["Independent", "Requires airway clearance", "Cough assist device in use"]),
checkboxLine("NIV / BiPAP Recommendation", ["Not yet indicated", "Discuss / plan for initiation", "Initiate – FVC <50% / symptomatic", "Already established"]),
...multiLine("Respiratory notes / plan:"),
spacer(),
// ═══════════════════════════════════════════
// SECTION 8 – Functional Mobility & Balance
// ═══════════════════════════════════════════
sectionHeader("SECTION 8 — FUNCTIONAL MOBILITY & BALANCE"),
spacer(),
...scoreTable("Functional Outcome Measures", [
"Timed Up and Go (TUG) – seconds",
"10-Metre Walk Test – seconds / speed (m/s)",
"6-Minute Walk Test – metres (if safe)",
"Berg Balance Scale (BBS) – /56",
"Sit-to-Stand (5 times) – seconds",
]),
checkboxLine("Gait Deviations", ["Foot drop / steppage gait", "Trendelenburg (hip abductor weakness)", "Head drop affecting balance", "Trunk instability", "Reduced arm swing", "None"]),
checkboxLine("Falls Risk", ["Low (BBS >45)", "Moderate (BBS 36-45)", "High (BBS <36)"]),
...multiLine("Fall history details / near-misses:"),
spacer(),
// ═══════════════════════════════════════════
// SECTION 9 – Posture & Pressure Care
// ═══════════════════════════════════════════
sectionHeader("SECTION 9 — POSTURE & PRESSURE CARE"),
spacer(),
checkboxLine("Head Drop", ["Absent", "Mild", "Moderate – collar considered", "Severe – collar required"]),
checkboxLine("Trunk Control", ["Good", "Mildly impaired", "Significantly impaired – supports required"]),
checkboxLine("Pressure Areas", ["Intact", "Red areas – at risk", "Grade 1 pressure injury", "Grade 2+", "Refer to tissue viability"]),
checkboxLine("Seating", ["Standard chair adequate", "Adapted seating", "Tilt-in-space wheelchair", "Custom moulded seating"]),
checkboxLine("Mattress", ["Standard", "Pressure-relieving foam", "Dynamic air mattress"]),
...multiLine("Postural management plan:"),
spacer(),
// ═══════════════════════════════════════════
// SECTION 10 – Staging
// ═══════════════════════════════════════════
sectionHeader("SECTION 10 — ALS STAGING (KING'S CLINICAL STAGING)"),
spacer(),
checkboxLine("Current Stage", [
"Stage 1 – Ambulant, minor deficits",
"Stage 2a – Independent, some functional limitation",
"Stage 2b – Dependent for some ADLs",
"Stage 3 – Wheelchair, reduced upper limb",
"Stage 4 – Dependent most ADLs",
"Stage 5 – End-stage / palliative",
]),
labelLine("ALSFRS-R decline rate (pts/month):", "King's stage at last visit:"),
spacer(),
// ═══════════════════════════════════════════
// SECTION 11 – Problem List
// ═══════════════════════════════════════════
new Paragraph({ children: [new PageBreak()] }),
sectionHeader("SECTION 11 — PHYSIOTHERAPY PROBLEM LIST"),
spacer(),
...["1.", "2.", "3.", "4.", "5.", "6."].flatMap((n) => [
new Paragraph({
spacing: { before: 60, after: 80 },
children: [
new TextRun({ text: n + " ", bold: true, size: 20, font: "Calibri", color: TEAL }),
new TextRun({ text: "_".repeat(110), size: 20, font: "Calibri", color: MID_GREY }),
],
}),
]),
spacer(),
// ═══════════════════════════════════════════
// SECTION 12 – Physiotherapy Goals
// ═══════════════════════════════════════════
sectionHeader("SECTION 12 — PHYSIOTHERAPY GOALS (SMART)"),
spacer(),
subHeader("Short-Term Goals (1-3 months)"),
...["1.", "2.", "3."].flatMap((n) => [
new Paragraph({
spacing: { before: 60, after: 80 },
children: [
new TextRun({ text: n + " ", bold: true, size: 20, font: "Calibri", color: TEAL }),
new TextRun({ text: "_".repeat(110), size: 20, font: "Calibri", color: MID_GREY }),
],
}),
]),
spacer(),
subHeader("Long-Term Goals (3-12 months)"),
...["1.", "2.", "3."].flatMap((n) => [
new Paragraph({
spacing: { before: 60, after: 80 },
children: [
new TextRun({ text: n + " ", bold: true, size: 20, font: "Calibri", color: TEAL }),
new TextRun({ text: "_".repeat(110), size: 20, font: "Calibri", color: MID_GREY }),
],
}),
]),
spacer(),
// ═══════════════════════════════════════════
// SECTION 13 – Intervention Plan
// ═══════════════════════════════════════════
sectionHeader("SECTION 13 — PHYSIOTHERAPY INTERVENTION PLAN"),
spacer(),
subHeader("13.1 Exercise Program"),
checkboxLine("Aerobic Exercise", ["Stationary cycling", "Walking program", "Hydrotherapy", "Arm ergometer", "None currently"]),
checkboxLine("Strengthening", ["Moderate resistance – preserved muscles", "Functional strengthening", "None – too weak / fatigued"]),
checkboxLine("Flexibility / Stretching", ["Active stretching", "Active-assisted ROM", "Passive ROM", "Carer-assisted home program"]),
labelLine("Exercise frequency (days/week):", "Session duration (mins):"),
smallNote("Safety rule: post-exercise fatigue must resolve within 30 minutes. Reduce load if this is exceeded."),
spacer(),
subHeader("13.2 Respiratory Physiotherapy"),
checkboxLine("Interventions Planned", ["Inspiratory Muscle Training (IMT)", "Expiratory Muscle Training (EMT)", "Manually Assisted Cough (MAC)"]),
checkboxLine("", ["Mechanical Insufflation-Exsufflation (Cough Assist)", "Air stacking / LVR", "HFCWO vest therapy"]),
checkboxLine("", ["NIV education and mask fitting", "Breathing pattern retraining", "Carer education in airway clearance"]),
spacer(),
subHeader("13.3 Mobility & Orthotics"),
checkboxLine("Orthotics / Aids", ["Ankle-foot orthosis (AFO) – R/L", "Cervical collar / head support", "Wrist splint", "Resting hand splint"]),
checkboxLine("", ["Walking stick", "Rollator", "Forearm crutches", "Manual wheelchair", "Powered wheelchair"]),
checkboxLine("", ["Stair rail installation advised", "Home modifications referral (OT)", "Ceiling hoist referral"]),
spacer(),
subHeader("13.4 Spasticity Management"),
checkboxLine("Physiotherapy Approach", ["Slow sustained stretching", "Positioning program", "Cryotherapy", "Hydrotherapy", "Splinting"]),
checkboxLine("Referral for", ["Botulinum toxin (focal spasticity)", "Intrathecal baclofen review", "None"]),
spacer(),
subHeader("13.5 Fatigue & Pain Management"),
checkboxLine("Fatigue Strategies", ["Activity pacing", "Energy conservation education", "Prioritisation of high-energy tasks to morning", "Sleep hygiene"]),
checkboxLine("Pain Management", ["Heat therapy", "TENS", "Joint ROM for stiffness", "Positioning / offloading", "Referral to pain team"]),
spacer(),
subHeader("13.6 Carer / Family Education"),
checkboxLine("Education Provided On", ["Safe manual handling", "Passive ROM home program", "Cough assist technique", "NIV use and care", "Pressure area prevention"]),
checkboxLine("", ["Fall prevention", "Adaptive equipment use", "Signs of respiratory deterioration", "Caregiver self-care / respite resources"]),
spacer(),
subHeader("13.7 Telehealth / Home Program"),
yesNoLine("Telehealth appropriate for this patient"),
yesNoLine("Written home exercise program provided"),
labelLine("Home program frequency:", "Review via telehealth:"),
spacer(),
// ═══════════════════════════════════════════
// SECTION 14 – MDT Referrals
// ═══════════════════════════════════════════
sectionHeader("SECTION 14 — MDT REFERRALS & COORDINATION"),
spacer(),
checkboxLine("Referrals Made", ["Occupational Therapy", "Speech & Language Therapy", "Dietitian / Nutritionist", "Respiratory Physician"]),
checkboxLine("", ["Palliative Care", "Psychology / Psychiatry", "Social Work", "Orthotics", "Community / Home PT"]),
...multiLine("Referral notes / reason:"),
spacer(),
// ═══════════════════════════════════════════
// SECTION 15 – Follow-Up Plan
// ═══════════════════════════════════════════
sectionHeader("SECTION 15 — FOLLOW-UP & REVIEW PLAN"),
spacer(),
checkboxLine("Follow-up Frequency", ["Every 2 weeks", "Monthly", "Every 2 months", "Every 3 months", "As needed"]),
labelLine("Next review date:", "Next ALSFRS-R to be completed:"),
labelLine("Next respiratory function test:", "Planned reassessment of goals:"),
...multiLine("Additional notes / special considerations:"),
spacer(),
// ═══════════════════════════════════════════
// SECTION 16 – Signature
// ═══════════════════════════════════════════
sectionHeader("SECTION 16 — CLINICIAN SIGN-OFF"),
spacer(),
labelLine("Physiotherapist Name (Print):", "Designation:"),
labelLine("Signature:", "Date:"),
labelLine("Countersigned (if applicable):", "Date:"),
smallNote("This form is a clinical record. Handle in accordance with patient data protection and confidentiality guidelines."),
spacer(),
];
// ─── Assemble Document ───────────────────────────────────────────────────────
const doc = new Document({
creator: "ALS Physiotherapy Clinic",
title: "ALS Physiotherapy Intake & Assessment Form",
description: "Structured physiotherapy intake and assessment form for patients with Amyotrophic Lateral Sclerosis",
styles: {
default: {
document: {
run: { font: "Calibri", size: 20 },
},
},
},
sections: [
{
properties: {
page: {
margin: { top: 720, bottom: 720, left: 900, right: 900 },
},
},
headers: {
default: new Header({
children: [
new Paragraph({
alignment: AlignmentType.RIGHT,
spacing: { after: 0 },
children: [
new TextRun({ text: "ALS Physiotherapy Intake Form | Page ", size: 17, font: "Calibri", color: "888888" }),
new TextRun({ children: [PageNumber.CURRENT], size: 17, font: "Calibri", color: "888888" }),
new TextRun({ text: " of ", size: 17, font: "Calibri", color: "888888" }),
new TextRun({ children: [PageNumber.TOTAL_PAGES], size: 17, font: "Calibri", color: "888888" }),
],
}),
],
}),
},
footers: {
default: new Footer({
children: [
new Paragraph({
alignment: AlignmentType.CENTER,
children: [
new TextRun({
text: "CONFIDENTIAL – Clinical Record | ALS / Motor Neuron Disease Service",
size: 16, font: "Calibri", color: "888888", italics: true,
}),
],
}),
],
}),
},
children,
},
],
});
Packer.toBuffer(doc).then((buffer) => {
fs.writeFileSync("/home/daytona/workspace/als-intake-form/ALS_Physiotherapy_Intake_Form.docx", buffer);
console.log("SUCCESS: Form generated at /home/daytona/workspace/als-intake-form/ALS_Physiotherapy_Intake_Form.docx");
});
cd /home/daytona/workspace/als-intake-form && node generate_form.js
python /home/daytona/skills/docx/scripts/office/validate.py /home/daytona/workspace/als-intake-form/ALS_Physiotherapy_Intake_Form.docx
python -c " import zipfile, os path = '/home/daytona/workspace/als-intake-form/ALS_Physiotherapy_Intake_Form.docx' size = os.path.getsize(path) print(f'File size: {size:,} bytes') with zipfile.ZipFile(path) as z: names = z.namelist() print('ZIP contents:', names[:10]) # Check document.xml is present and non-empty with z.open('word/document.xml') as f: content = f.read() print(f'document.xml size: {len(content):,} bytes') print('Valid XML start:', content[:200]) "
ALS Physiotherapy Intake Form
Word Document · DOCX
| # | Section | Contents |
|---|---|---|
| 1 | Patient Demographics | Name, MRN, DOB, ALS type, onset region, genetic subtype |
| 2 | Subjective History | Presenting complaints, symptom profile, fatigue (FSS), pain (NRS), respiratory symptoms, social/home environment, medications, patient goals |
| 3 | Objective Assessment | General observations + full ALSFRS-R table (12 items, /48) with rate-of-decline field |
| 4 | Muscle Strength | Full MRC table for 13 bilateral muscle groups + grip/pinch dynamometry |
| 5 | Tone & Spasticity | UMN/LMN sign checklist + Modified Ashworth Scale table (8 regions bilaterally) |
| 6 | Range of Motion | 8 joint measurements bilaterally + contracture checklist |
| 7 | Respiratory Assessment | Full respiratory table - FVC seated/supine, SNIP, MIP, MEP, PCF with clinical thresholds annotated; NIV recommendation |
| 8 | Functional Mobility & Balance | TUG, 10MWT, 6MWT, Berg Balance Scale, 5xSTS; gait deviation checklist; falls risk stratification |
| 9 | Posture & Pressure Care | Head drop, trunk control, pressure areas, seating, mattress |
| 10 | ALS Staging | King's Clinical Staging (Stages 1-5) with ALSFRS-R decline rate |
| 11 | Problem List | 6 numbered free-text problem entries |
| 12 | SMART Goals | Short-term (1-3 months) and long-term (3-12 months) goal boxes |
| 13 | Intervention Plan | Exercise, respiratory physiotherapy, mobility/orthotics, spasticity, fatigue/pain, carer education, telehealth |
| 14 | MDT Referrals | OT, SLT, Dietitian, Respiratory, Palliative, Psychology, Social Work |
| 15 | Follow-up Plan | Frequency, next review dates, reassessment schedule |
| 16 | Clinician Sign-Off | Signature, designation, countersign, confidentiality notice |
Give the short note on the patho physiology in als
| Gene | Mechanism | Proportion |
|---|---|---|
| C9ORF72 (chr 9) | GGGGCC hexanucleotide repeat expansion | 40-50% of familial; 7-10% sporadic |
| SOD1 (chr 21q22) | Superoxide dismutase 1 mutations | 20% familial; 2% overall |
| TDP-43 (TARDBP) and FUS | RNA-binding protein mutations | Minority of familial cases |
Genetic trigger / environmental stress
↓
Protein misfolding → aggregation (SOD1, TDP-43, FUS)
↓
Excitotoxicity + Oxidative stress + Mitochondrial failure
↓
Impaired axonal transport + RNA processing defects
↓
Motor neuron apoptosis (UMN + LMN)
↓
UMN loss: corticospinal tract degeneration → spasticity, hyperreflexia
LMN loss: anterior horn cell death → denervation, wasting, fasciculations
↓
Progressive paralysis → respiratory failure → death
| Mechanism | Target | Result |
|---|---|---|
| Excitotoxicity (glutamate) | NMDA/AMPA receptors → Ca²⁺ overload | Apoptosis |
| Oxidative stress (SOD1 mutation) | Membrane lipids, DNA, proteins | Cell death |
| Protein aggregation (TDP-43, SOD1) | Cytoplasmic inclusions | Loss of function + toxic gain |
| RNA processing defects (C9ORF72, FUS) | mRNA splicing/transport | Neuronal dysfunction |
| Mitochondrial failure | ATP production | Energy deprivation |
| Axonal transport failure | Long motor axons | Axon degeneration |
| Astrocyte/microglial toxicity | Neighbouring motor neurons | Amplified neuronal death |
Best digram for the exam in als topic
Which diagram would be most useful for your exam?
Medical exam study diagram: ALS Pathophysiology Flowchart. Clean, professional infographic with a dark teal and white color scheme. Title at top: "ALS PATHOPHYSIOLOGY". Show a vertical cascade flowchart with labeled boxes and arrows: Box 1 "GENETIC TRIGGERS" listing C9ORF72 hexanucleotide repeat (most common), SOD1 mutation (chr 21), TDP-43 / FUS mutations. Arrow down to Box 2 "CORE MECHANISMS" with 6 colored sub-boxes in a row: (1) Excitotoxicity - glutamate excess, Ca2+ overload; (2) Oxidative Stress - ROS accumulation; (3) Protein Aggregation - TDP-43 inclusions; (4) RNA Processing Defects - dipeptide repeat proteins; (5) Mitochondrial Dysfunction - ATP failure; (6) Axonal Transport Failure. Arrow down to Box 3 "NON-NEURONAL TOXICITY" - mutant astrocytes and microglia amplify motor neuron death. Arrow down to Box 4 "MOTOR NEURON APOPTOSIS" - UMN (motor cortex) and LMN (anterior horn / brainstem). Arrow down to two side-by-side boxes: Left "UMN LOSS" = spasticity, hyperreflexia, Babinski sign, pseudobulbar palsy. Right "LMN LOSS" = wasting, weakness, fasciculations, flaccidity. Bottom box "RESPIRATORY FAILURE = cause of death". Include a small note: "Spared: eye muscles (CN III/IV/VI) and Onuf's nucleus (bowel/bladder)". Clean medical textbook style, readable font sizes, white background.
Medical exam study diagram: UMN vs LMN Signs in ALS. Professional two-column comparison table infographic. Title: "UMN vs LMN SIGNS IN ALS". Left column header "UPPER MOTOR NEURON (UMN)" in dark teal with brain/cortex icon. Right column header "LOWER MOTOR NEURON (LMN)" in navy blue with spinal cord icon. UMN column rows: Spasticity (increased tone), Hyperreflexia (brisk reflexes), Babinski sign (extensor plantar), Hoffman sign, Clonus, Pseudobulbar palsy (emotional lability, brisk jaw jerk, strained speech), Loss of dexterity, Absent abdominal reflexes. LMN column rows: Flaccidity (reduced tone), Hyporeflexia / areflexia, Fasciculations, Muscle wasting (amyotrophy), Weakness, Flaccid dysarthria (nasal quality), Dysphagia, Cramps. Center column labeled "CLASSIC ALS PARADOX" = brisk reflexes IN a wasted limb (hallmark). Bottom note in a highlighted box: "ALS = BOTH UMN + LMN signs present simultaneously - KEY DIAGNOSTIC CLUE". Clean white background, colored rows alternating, professional medical illustration style.
Medical exam study diagram: ALS Clinical Presentation by Onset Type. Clean professional infographic, white background, teal and dark blue color scheme. Title: "ALS CLINICAL PRESENTATIONS". Central label "ALS ONSET REGION". Four radiating sections arranged around center: Section 1 top-left "SPINAL UPPER LIMB (most common)" - hand/finger weakness, thenar wasting, claw hand, difficulty buttoning/key-turning; Section 2 top-right "SPINAL LOWER LIMB" - foot drop, steppage gait, falls, ankle weakness; Section 3 bottom-left "BULBAR ONSET (25%)" - slurred speech first, then dysphagia (liquids before solids), sialorrhea, nasal voice, facial weakness, tongue fasciculations, common in elderly women; Section 4 bottom-right "RESPIRATORY ONSET (1-2%)" - dyspnea, orthopnea, fail ventilator weaning, predominantly male. Below, a progression timeline arrow: "Focal onset → contiguous spread → all 4 limbs + bulbar + respiratory → Death from respiratory failure (mean 2-5 years)". Small box: "PRESERVED: Eye movements, Bowel/Bladder (Onuf nucleus)". Neat icons for each region, clear labels, medical textbook quality.
Medical exam study diagram: ALS Physiotherapy Assessment Summary. Professional clinical reference card infographic. Title: "ALS PHYSIOTHERAPY ASSESSMENT AT A GLANCE". Organized into 6 colored sections: Section 1 (teal) "FUNCTION" - ALSFRS-R /48, King's Staging 1-5, ADL independence; Section 2 (navy) "MUSCLE STRENGTH" - MRC scale 0-5, bilateral testing, grip/pinch dynamometry, thenar atrophy; Section 3 (dark red) "RESPIRATORY - CRITICAL" with alert icon - FVC seated AND supine (drop >25% = significant), SNIP <40 cmH2O, MIP <60 = inspiratory weakness, MEP <60 = impaired cough, Peak Cough Flow <160 L/min = ineffective cough, NIV when FVC <50%; Section 4 (green) "MOBILITY & BALANCE" - TUG, 10MWT, Berg Balance Scale /56, falls risk, gait deviations (foot drop, head drop); Section 5 (purple) "FATIGUE" - FSS >36 = significant, post-exercise fatigue >30 min = REDUCE LOAD safety rule; Section 6 (orange) "INTERVENTION PILLARS" - Moderate exercise (no overwork), Respiratory physio (IMT/EMT/cough assist), ROM/stretching, Orthotics (AFO/collar), Energy conservation, Carer education. Clean white background, each section clearly boxed and colored, readable font, professional medical education style.
Amyotrophic lateral scloresuis details exam based answer
Medical exam study diagram: ALS Pathophysiology Flowchart. Clean professional infographic, dark teal and white color scheme. Title at top: "ALS PATHOPHYSIOLOGY". Vertical cascade flowchart. Box 1 "GENETIC TRIGGERS": C9ORF72 hexanucleotide repeat most common, SOD1 mutation chr 21, TDP-43 and FUS mutations. Arrow down to Box 2 "CORE MECHANISMS" with 6 sub-boxes: Excitotoxicity glutamate excess Ca2+ overload; Oxidative Stress ROS accumulation; Protein Aggregation TDP-43 inclusions; RNA Processing Defects dipeptide repeat proteins; Mitochondrial Dysfunction ATP failure; Axonal Transport Failure. Arrow down to Box 3 "NON-NEURONAL TOXICITY" mutant astrocytes and microglia amplify death. Arrow down to Box 4 "MOTOR NEURON APOPTOSIS" UMN motor cortex and LMN anterior horn brainstem. Arrow to two boxes: UMN LOSS spasticity hyperreflexia Babinski; LMN LOSS wasting weakness fasciculations. Bottom: "RESPIRATORY FAILURE = cause of death". Note: "Spared: eye muscles and Onuf nucleus bowel bladder". Clean medical textbook style white background readable fonts
Medical exam study comparison table infographic. Title "UMN vs LMN SIGNS IN ALS". Two columns. Left column header "UPPER MOTOR NEURON UMN" in dark teal. Rows: Spasticity increased tone, Hyperreflexia brisk reflexes, Babinski sign extensor plantar, Hoffman sign, Clonus, Pseudobulbar palsy emotional lability brisk jaw jerk strained speech, Loss of dexterity, Absent abdominal reflexes. Right column header "LOWER MOTOR NEURON LMN" in navy blue. Rows: Flaccidity reduced tone, Hyporeflexia areflexia, Fasciculations, Muscle wasting amyotrophy, Weakness, Flaccid dysarthria nasal quality, Dysphagia, Cramps. Center highlighted box "CLASSIC ALS PARADOX: Brisk reflexes IN a wasted limb = hallmark diagnostic clue". Bottom box "ALS = BOTH UMN plus LMN signs simultaneously". White background alternating colored rows professional medical style
Medical exam study diagram ALS Clinical Presentations. Clean infographic white background teal and dark blue. Title "ALS ONSET TYPES AND CLINICAL FEATURES". Four quadrant layout around central circle "ALS". Top left quadrant "SPINAL UPPER LIMB most common": hand finger weakness, thenar wasting, claw hand, difficulty buttoning key turning. Top right quadrant "SPINAL LOWER LIMB": foot drop, steppage gait, falls, ankle weakness. Bottom left quadrant "BULBAR ONSET 25 percent": slurred speech first, dysphagia liquids before solids, sialorrhea, nasal voice, tongue fasciculations, common in elderly women. Bottom right quadrant "RESPIRATORY ONSET 1 to 2 percent": dyspnea orthopnea, fail ventilator weaning, male predominant. Bottom timeline arrow "Focal onset to contiguous spread to all regions to respiratory failure death mean 2 to 5 years". Small box "PRESERVED: Eye movements and Bowel Bladder Onuf nucleus". Professional medical education infographic style
Medical exam reference card infographic. Title "ALS PHYSIOTHERAPY ASSESSMENT AND MANAGEMENT SUMMARY". Six colored sections arranged in grid. Section 1 teal "FUNCTIONAL RATING": ALSFRS-R score out of 48, Kings Staging 1 to 5, decline greater than 1 point per month equals fast progression. Section 2 navy "MUSCLE STRENGTH": MRC scale 0 to 5, bilateral testing all major groups, thenar atrophy early sign, grip pinch dynamometry. Section 3 red with alert "RESPIRATORY CRITICAL": FVC seated and supine drop greater than 25 percent significant, SNIP less than 40 cmH2O, MIP less than 60 inspiratory weakness, Peak Cough Flow less than 160 ineffective cough, NIV when FVC less than 50 percent. Section 4 green "MOBILITY AND BALANCE": TUG test, 10 metre walk test, Berg Balance Scale out of 56, foot drop and head drop assessment, falls risk. Section 5 purple "FATIGUE SAFETY RULE": FSS greater than 36 significant fatigue, post-exercise fatigue more than 30 minutes equals reduce load immediately. Section 6 orange "INTERVENTIONS": Moderate exercise no overwork, IMT EMT cough assist respiratory, ROM stretching daily, AFO collar orthotics, energy conservation, carer education. White background professional clinical education card style clear fonts
429 Too Many Requests. {'message': '{\n "error": {\n "code": 429,\n "message": "Resource exhausted. Please try again later. Please refer to https://cloud.google.com/vertex-ai/generative-ai/docs/error-code-429 for more details.",\n "status": "RESOURCE_EXHAUSTED"\n }\n}\n', 'status': 'Too Many Requests'}
We encountered an error while processing your request. Please try again or reach out to us for help.